Topics

Glioblastoma | Treatment | Clinical trials

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials

□ OVERVIEW

□ UMBRELLA TRIALS

BIOMARKERS

□ EXTRACELL PARTICLES

CHEMOTHERAPY

□ CARBOPLATIN

□ DRUG DELIVERY

□ IRINOTECAN

□ LOMUSTINE

□ LURBINECTEDIN

□ METHOXYAMINE

□ NEOADJUVANT CHEMOTHER

□ R-(-)-GOSSYPOL

□ TAXANES

□ TEMOZOLOMIDE

□ TOPOTECAN

DIAGNOSIS / ASSESSMENT

□ OLFACTORY FUNCTION

□ POSITRON EMISS TOMOGR

ELECTRIC / MAGNETIC FIELDS

□ TUMOR TREATING FIELDS

GENE THERAPY

□ AGLATIMAGENE BESADENOVEC

IMMUNOTHERAPY

□ ATEZOLIZUMAB

□ BISPEC ANTIB ARM T CELLS

□ CAR-T-CELLS

□ CELL THERAPY

□ DENDRITIC CELLS

□ EFFICACY

□ GM-CSF

□ IMMUNE CHECKP INHIBIT

□ mTOR INHIBITORS

□ VACCINES

□ VIRUSES

INTEGRATIVE MEDICINE

□ CIRCADIAN CLOCK

□ KETOGENIC METABOL THER

□ NIACIN

□ NUTRACEUTICALS

□ PERILLYL ALCOHOL

□ VITAMINS

LASER THERAPIES

□ LASER INTERST THERMAL THER

NUCLEAR MEDICINE

□ THERANOSTICS

PHARMACOTHERAPY

□ ANTIEMETIC DRUGS

□ ANTIEPILEPTIC DRUGS

□ ANTISECRETORY FACTOR

□ ARSENICALS

□ CHLOROTOXIN

□ CONTRACEPTIVE DRUGS

□ DISULFIRAM

□ IMMUNOSUPPR DRUGS

RADIOTHERAPY

□ BORON NEUTR CAPT THER

□ EXTERNAL BEAM RADIAT THER

□ FRACTIONATED

□ MARGINS

□ PHOTODYNAMIC THERAPY

□ PROTON BEAM

□ RADIOPHARMACEUTICALS

□ RADIOSENSITIZERS

□ RE-IRRADIATION

□ RESPONSE-ADAPTIVE

SIDE EFFECTS

□ THROMBOEMBOLISM

SUPPORTIVE CARE

□ CAREGIVERS

□ PALLIATIVE CARE

SURGERY

□ BIOPSY

□ FLAIRECTOMY

□ FLUORESC-GUIDED SURG

□ RESECTION CAVITY

□ RESECTION EXTENT

TARGETED THERAPY

□ ABEMACICLIB

□ ADAVOSERTIB

□ AFATINIB

□ ALECTINIB

□ APTAMERS

□ AVUTOMETINIB

□ BEVACIZUMAB

□ BELZUTIFAN

□ DABRAFENIB

□ DASATINIB

□ DEPATUXIZUMAB

□ DRUG SCREENING

□ DURVALUMAB

□ DEFACTINIB

□ GLASDEGIB

□ GLUTAMATE SIGN INHIBIT

□ IDASANUTLIN

□ IDO1 INHIBITORS

□ IPILIMUMAB

□ IPATASERTIB

□ KHK2455

□ KINASE INHIBITORS

□ LENVATINIB

□ LISAVANBULIN

□ MARIZOMIB

□ MICROENV MODULATORS

□ MOGAMULIZUMAB

□ NAVTEMADLIN

□ NIVOLUMAB

□ NIRAPARIB

□ OLAPARIB

□ PALBOCICLIB

□ PAMIPARIB

□ PD-L1 TARGETED THERAPY

□ PEMBROLIZUMAB

□ PEXIDARTINIB

□ PAZOPANIB

□ RINDOPEPIMUT

□ RO7428731

□ REGORAFENIB

□ SACITUZUMAB GOVITECAN

□ SUNITINIB

□ SENICAPOC

□ TEMSIROLIMUS

□ TISLELIZUMAB

□ TRAMETINIB

□ TREMELIMUMAB

□ VAL-083

□ VELIPARIB

□ VISMODEGIB

□ VEBRELTINIB

ULTRASOUND THERAPY

□ FOCUSED ULTRASOUND

VARIANTS

□ MOLECULAR GLIOBLASTOMA